Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Blood Tests And Bone Marrow Biopsy Repeated

Research Leaders

15 sponsors active, led by CHRU LILLE

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT01648556Not ApplicableCompletedPrimary

Research of Predictive Factors to Immune Thrombopenic Purpura

Showing all 1 trials

Research Network

Common Treatments

  • Blood Tests And Bone Marrow Biopsy Repeated1

Active Sponsors

  • CHRU LILLE1
  • Henri Mondor University Hospital1
  • Assistance Publique Hopitaux De Marseille1
  • Centre Hospitalier Universitaire de Besancon1
  • Abbeville Hospital Center1

Top Investigators

Activity Timeline